Liverpool John Moores University
Liverpool, L33AF, United Kingdom
NCT Number: NCT03598400
There is clear evidence that regular exercise improves wellbeing and reduces the risk of diabetes related complications in people with type 1 diabetes. However, many people with type 1 diabetes do not exercise regularly. The primary reason for this is fear of hypoglycaemia and loss of glycaemic control associated with exercise. This loss of glycaemic control is associated with traditional moderate intensity continous aerobic exercise advocated in the guidelines for exercise in people with type 1 diabetes. Recent work (unpublished) from our lab suggests high intensity interval training (HIT) may reduce the risk of hypoglycaemia in people with type 1 diabetes, however stronger evidence is needed before firm conclusions can be drawn.
Therefore, the aim of this study is to determine the effects of HIT on glycaemic control in people with type 1 diabetes compared to no exercise and traditional moderate intensity continous exercise.
24 people with type 1 diabetes will be recruited to complete a randomised counterbalanced cross over study comparing 3x 2-week interventions periods. During these intervention periods participant will maintain their habitual lifestyle but complete either no exercise (control), traditional moderate intensity continous exercise or high intensity interval training. Throughout the intervention periods participants glycaemic control will be monitored using a flash glucose monitor.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Not applicable
Liverpool, L33AF, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will complete 6 sessions of high intensity interval training during a 2 week intervention period. The programme involves repeated 1 minute bouts of simple on the spot movements interspersed with 1 minute of rest.
Participants will complete 6 sessions of moderate intensity continous training during a 2 week intervention period. Participants will be asked to complete 30 minutes of continuous exercise.
Time frame: 2 weeks
Number of severe hypoglycaemic events (<3mmol/l) during the 2 week intervention period
Time frame: 2 weeks
mean glucose level over 2 week recording period
Time frame: 2 weeks
% of time in level 2 hypoglycaemia (<3.0mmol/L) over 2 week recording period
Time frame: 2 weeks
% of time in level 1 hypoglycaemia (3.0-3.9mmol/L) over 2 week recording period
Time frame: 2 weeks
% of time in target range (3.9-10.0mmol/L) over 2 week recording period
Time frame: 2 weeks
% of time in level 1 hyperglycaemia (10.0-13.9mmol/L) over 2 week recording period
Time frame: 2 weeks
% of time in level 2 hyperglycaemia (>13.9mmol/L) over 2 week recording period
Time frame: 2 weeks
glycaemic variability over 2 week recording period
Time frame: 2 weeks
area under the curve of episodes of hypoglycaemia and hyperglycaemia 2 week recording period
Liverpool John Moores University
Other
Can High Intensity Interval Training Reduce Fear of Hypoglycaemia and Improve Glycaemic Control in People With Type 1 Diabetes?
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03761186
Autoimmune Diseases, Diabetes Mellitus
Stockholm, Sweden
View Trial DetailsNCT05557227
Glucose Metabolism Disorders, Hyperglycemia
Aarhus, Region Midt, Denmark
View Trial DetailsNCT06115616
Type1diabetes
Aarhus, Denmark
View Trial DetailsNCT05662267
Autoimmune Diseases, Chronic Disease
Lille, France
View Trial Details